Copyright
©The Author(s) 2024.
World J Stem Cells. Jun 26, 2024; 16(6): 641-655
Published online Jun 26, 2024. doi: 10.4252/wjsc.v16.i6.641
Published online Jun 26, 2024. doi: 10.4252/wjsc.v16.i6.641
Table 1 Study group characteristics
Characteristics | n | % | |
Age (yr) | 21 | 1 | 16.7 |
22 | 1 | 16.7 | |
25 | 2 | 33.3 | |
26 | 1 | 16.7 | |
27 | 1 | 16.7 | |
Sex | Female | 2 | 33.3 |
Male | 4 | 66.7 | |
Cause of spinal cord injury | Traffic accident | 6 | 100.0 |
Comorbidity | None | 6 | 100.0 |
Treatments before transplantation | Non-surgical | 2 | 33.3 |
Decompressive craniectomy | 1 | 16.7 | |
Acute subdural hematoma evacuation and ventriculoperitoneal shunt | 1 | 16.7 | |
Decompressive craniectomy and ventriculoperitoneal shunt | 1 | 16.7 | |
Ventriculoperitoneal shunt | 1 | 16.7 | |
Duration between spinal cord injury and first transplantation | 6 months | 1 | 16.7 |
18 months | 1 | 16.7 | |
22 months | 1 | 16.7 | |
24 months | 2 | 33.3 | |
48 months | 1 | 16.7 |
Table 2 Administration schedule
Date | Route | WJ-MSCs |
Round 1 | ||
I.t. | 1 × 106/kg (3 mL in total) | |
I.v. | 1 × 106/kg (30 mL in total) | |
I.m. | 1 × 106/kg (20 mL in total) | |
Round 2 (2nd wk) | ||
I.t. | 1 × 106/kg (3 mL in total) | |
I.v. | 1 × 106/kg (30 mL in total) | |
I.m. | 1 × 106/kg (20 mL in total) | |
Round 3 (1st month) | ||
I.t. | 1 × 106/kg (3 mL in total) | |
I.v. | 1 × 106/kg (30 mL in total) | |
I.m. | 1 × 106/kg (20 mL in total) | |
Round 4 (2nd month) | ||
I.t. | 1 × 106/kg (3 mL in total) | |
I.v. | 1 × 106/kg (30 mL in total) | |
I.m. | 1 × 106/kg (20 mL in total) | |
Round 5 (3rd month) | ||
I.t. | 1 × 106/kg (3 mL in total) | |
I.v. | 1 × 106/kg (30 mL in total) | |
I.m. | 1 × 106/kg (20 mL in total) | |
Round 6 (4th month) | ||
I.t. | 1 × 106/kg (3 mL in total) | |
I.v. | 1 × 106/kg (30 mL in total) | |
I.m. | 1 × 106/kg (20 mL in total) |
Table 3 Friedman test results of the changes observed in the Functional Independence Measure Motor Score values of the patients before and after the intervention
n | Mean | SD | Mean rank | χ2 | df | P value | |
Preoperative | 6 | 13.17 | 0.41 | 2.67 | 14.310 | 5 | 0.014 |
Postoperative 1st wk | 6 | 13.17 | 0.41 | 2.67 | |||
Postoperative 1st month | 6 | 13.33 | 0.82 | 2.92 | |||
Postoperative 2nd month | 6 | 14.17 | 1.60 | 4.08 | |||
Postoperative 4th month | 6 | 14.33 | 1.97 | 4.33 | |||
Postoperative 1st yr | 6 | 14.33 | 1.97 | 4.33 |
Table 4 Functional Independence Measure Motor Score values of each patient
FIM Scale, Motor Score: Self-care/Sphincter Control/Transfers/Locomotion | ||||||
Pre-test | Post-test (1st wk) | Post-test (1st month) | Post-test (2nd month) | Post-test (4th month) | Post-test (12th month) | |
Patient 1 | 13 | 13 | 13 | 15 | 15 | 15 |
Patient 2 | 14 | 14 | 15 | 17 | 18 | 18 |
Patient 3 | 13 | 13 | 13 | 13 | 13 | 13 |
Patient 4 | 13 | 13 | 13 | 14 | 14 | 14 |
Patient 5 | 13 | 13 | 13 | 13 | 13 | 13 |
Patient 6 | 13 | 13 | 13 | 13 | 13 | 13 |
Table 5 Friedman test results of the changes observed in the Functional Independence Measure Cognitive Score values of the patients before and after the intervention
n | Mean | SD | Mean rank | χ2 | df | P value | |
Preoperative | 6 | 5.67 | 1.63 | 1.58 | 26.160 | 5 | 0.000 |
Postoperative 1st wk | 6 | 6.50 | 1.76 | 2.08 | |||
Postoperative 1st month | 6 | 7.67 | 2.42 | 2.92 | |||
Postoperative 2nd month | 6 | 8.83 | 3.49 | 3.75 | |||
Postoperative 6th month | 6 | 11.00 | 4.43 | 4.92 | |||
Postoperative 1st yr | 6 | 11.83 | 3.97 | 5.75 |
Table 6 Functional Independence Measure Cognitive Score values of each patient
FIM Scale, Cognitive Score: Communication/Social Cognition (TS:35) | ||||||
Pre-test | Post-test (1st wk) | Post-test (1st month) | Post-test (2nd month) | Post-test (4th month) | Post-test (12th month) | |
Patient 1 | 5 | 5 | 8 | 9 | 11 | 11 |
Patient 2 | 9 | 9 | 12 | 15 | 17 | 18 |
Patient 3 | 5 | 5 | 6 | 6 | 8 | 8 |
Patient 4 | 5 | 7 | 7 | 9 | 15 | 15 |
Patient 5 | 5 | 8 | 8 | 9 | 10 | 11 |
Patient 6 | 5 | 5 | 5 | 5 | 5 | 8 |
Table 7 Friedman test results of the changes observed in the Modified Ashworth Score right values of the patients before and after the intervention
n | Mean | SD | Mean rank | χ2 | df | P value | |
Preoperative | 6 | 19.83 | 4.58 | 5.58 | 28.641 | 5 | 0.000 |
Postoperative 1st wk | 6 | 19.50 | 4.46 | 5.33 | |||
Postoperative 1st month | 6 | 17.33 | 4.68 | 4.00 | |||
Postoperative 2nd month | 6 | 16.17 | 5.35 | 2.83 | |||
Postoperative 4th month | 6 | 15.17 | 4.99 | 1.83 | |||
Postoperative 1st yr | 6 | 13.83 | 4.83 | 1.42 |
Table 8 Modified Ashworth Score right values of each patient
Modified Ashworth Score (right) | ||||||
Pre-test | Post-test (1st wk) | Post-test (1st month) | Post-test (2nd month) | Post-test (4th month) | Post-test (12th month) | |
Patient 1 | 19 | 19 | 16 | 14 | 12 | 12 |
Patient 2 | 20 | 20 | 16 | 15 | 14 | 14 |
Patient 3 | 20 | 20 | 18 | 17 | 16 | 11 |
Patient 4 | 26 | 26 | 24 | 24 | 22 | 22 |
Patient 5 | 12 | 12 | 10 | 8 | 8 | 8 |
Patient 6 | 22 | 20 | 20 | 19 | 19 | 16 |
Table 9 Friedman test results of the changes observed in the Modified Ashworth Score left values of the patients before and after the intervention
n | Mean | SD | Mean rank | χ2 | df | P value | |
Preoperative | 6 | 18.83 | 5.04 | 5.58 | 28.462 | 5 | 0.000 |
Postoperative 1st wk | 6 | 18.50 | 4.85 | 5.25 | |||
Postoperative 1st month | 6 | 16.33 | 4.68 | 3.83 | |||
Postoperative 2nd month | 6 | 15.83 | 5.04 | 3.25 | |||
Postoperative 4th month | 6 | 14.33 | 4.18 | 1.83 | |||
Postoperative 1st yr | 6 | 13.00 | 4.60 | 1.25 |
Table 10 Modified Ashworth Score left values of each patient
Modified Ashworth Score (left) | ||||||
Pre-test | Post-test (1st wk) | Post-test (1st month) | Post-test (2nd month) | Post-test (4th month) | Post-test (12th month) | |
Patient 1 | 19 | 19 | 16 | 16 | 14 | 12 |
Patient 2 | 20 | 20 | 15 | 14 | 13 | 13 |
Patient 3 | 20 | 20 | 18 | 17 | 16 | 11 |
Patient 4 | 23 | 23 | 21 | 21 | 19 | 19 |
Patient 5 | 9 | 9 | 8 | 7 | 7 | 6 |
Patient 6 | 22 | 20 | 20 | 20 | 17 | 17 |
Table 11 Friedman test results of the changes observed in the Medical Research Council muscle strength scale right values of the patients before and after the intervention
n | Mean | SD | Mean rank | χ2 | df | P value | |
Preoperative | 6 | 3.33 | 1.86 | 2.58 | 13.214 | 5 | 0.021 |
Postoperative 1st wk | 6 | 3.33 | 1.86 | 2.58 | |||
Postoperative 1st month | 6 | 3.67 | 1.51 | 3.33 | |||
Postoperative 2nd month | 6 | 4.00 | 1.10 | 4.00 | |||
Postoperative 4th month | 6 | 4.17 | 0.98 | 4.25 | |||
Postoperative 1st yr | 6 | 4.17 | 0.98 | 4.25 |
Table 12 Medical Research Council muscle strength scale right values of each patient
MRC muscle strength scale (right) | ||||||
Pre-test | Post-test (1st wk) | Post-test (1st month) | Post-test (2nd month) | Post-test (4th month) | Post-test (12th month) | |
Patient 1 | 2 | 2 | 2 | 3 | 3 | 3 |
Patient 2 | 2 | 2 | 3 | 3 | 3 | 3 |
Patient 3 | 5 | 5 | 5 | 5 | 5 | 5 |
Patient 4 | 1 | 1 | 2 | 3 | 4 | 4 |
Patient 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Patient 6 | 5 | 5 | 5 | 5 | 5 | 5 |
Table 13 Friedman test results of the changes observed in the Medical Research Council muscle strength scale left values of the patients before and after the intervention
n | Mean | SD | Mean rank | χ2 | df | P value | |
Preoperative | 6 | 3.33 | 1.86 | 2.58 | 13.506 | 5 | 0.019 |
Postoperative 1st wk | 6 | 3.33 | 1.86 | 2.58 | |||
Postoperative 1st month | 6 | 3.67 | 1.51 | 3.25 | |||
Postoperative 2nd month | 6 | 4.00 | 1.10 | 4.08 | |||
Postoperative 4th month | 6 | 4.00 | 1.10 | 4.08 | |||
Postoperative 1st yr | 6 | 4.17 | 0.98 | 4.42 |
Table 14 Medical Research Council muscle strength scale left values of each patient
MRC muscle strength scale (left) | ||||||
Pre-test | Post-test (1st wk) | Post-test (1st month) | Post-test (2nd month) | Post-test (4th month) | Post-test (12th month) | |
Patient 1 | 2 | 2 | 2 | 3 | 3 | 3 |
Patient 2 | 2 | 2 | 3 | 3 | 3 | 4 |
Patient 3 | 5 | 5 | 5 | 5 | 5 | 5 |
Patient 4 | 1 | 1 | 2 | 3 | 3 | 3 |
Patient 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Patient 6 | 5 | 5 | 5 | 5 | 5 | 5 |
Table 15 Friedman test results of the changes observed in the Karnofsky performance scale values of the patients before and after the intervention
n | Mean | SD | Mean rank | χ2 | df | P value | |
Preoperative | 6 | 15.00 | 5.48 | 1.92 | 27.557 | 5 | 0.000 |
Postoperative 1st wk | 6 | 15.00 | 5.48 | 1.92 | |||
Postoperative 1st month | 6 | 21.67 | 11.69 | 2.92 | |||
Postoperative 2nd month | 6 | 23.33 | 12.11 | 3.25 | |||
Postoperative 4th month | 6 | 33.33 | 12.11 | 5.33 | |||
Postoperative 1st yr | 6 | 36.67 | 15.06 | 5.67 |
Table 16 Karnofsky performance scale values of each patient
Karnofsky performance scale | ||||||
Pre-test | Post-test (1st wk) | Post-test (1st month) | Post-test (2nd month) | Post-test (4th month) | Post-test (12th month) | |
Patient 1 | 10 | 10 | 20 | 20 | 30 | 30 |
Patient 2 | 20 | 20 | 40 | 40 | 50 | 50 |
Patient 3 | 20 | 20 | 20 | 30 | 40 | 50 |
Patient 4 | 20 | 20 | 30 | 30 | 40 | 50 |
Patient 5 | 10 | 10 | 10 | 10 | 20 | 20 |
Patient 6 | 10 | 10 | 10 | 10 | 20 | 20 |
- Citation: Kabatas S, Civelek E, Boyalı O, Sezen GB, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Safety and efficiency of Wharton’s Jelly-derived mesenchymal stem cell administration in patients with traumatic brain injury: First results of a phase I study. World J Stem Cells 2024; 16(6): 641-655
- URL: https://www.wjgnet.com/1948-0210/full/v16/i6/641.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i6.641